The rising prevalence in GLP-1 agonists for diabetes has sparked a question about formats: skin-applied devices versus tablets . Typically, GLP-1 therapies were solely available in oral form, but the https://laylartpj659335.ja-blog.com/41260739/glp-1-transdermal-delivery-systems-vs-pills-what-best-for-individuals